Extended Paxlovid Treatment Shows Mixed Results for Long COVID
A case series of 13 patients suggests that extended courses of Paxlovid could benefit some Long COVID patients, but the results are inconsistent.
A case series of 13 patients suggests that extended courses of Paxlovid could benefit some Long COVID patients, but the results are inconsistent.
University of California, Los Angeles is hiring. Apply now!
For years, John Fleischman carried the journal of his late mentor, who died from HIV/AIDS. He finally found the perfect home for it at the…
Twee weken voor zijn inauguratie als president kwam Donald Trump vandaag opnieuw met opmerkelijke plannen.
Researchers are prepared to analyze immune cells from human samples should H5N1 begin spreading between people.
Access free, up-to-date clinical guidance on Measles at Healio. We offer valuable insights for identifying, assessing, treating and managing this condition.
Illustration depicting a chlamydia-infected cell. Chlamydia trachomatis bacteria (represented by small dark spher…
Clarametyx Biosciences will receive $2.6 million from CARB-X to develop CMTX-301, a vaccine designed to prevent bacterial biofilm formation.
But the average number and duration of the episodes didn’t differ significantly between the groups, and there were no serious adverse events.
Eighty-seven percent of hospitalizations and 89% of resident deaths took place before widespread vaccination.